Derek Adams
Directeur/Bestuurslid bij ALLOVIR, INC.
Vermogen: 28 000 $ op 30-04-2024
Actieve functies van Derek Adams
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALLOVIR, INC. | Directeur/Bestuurslid | 01-03-2023 | - |
| Independent Dir/Board Member | 01-03-2023 | - |
Loopbaan van Derek Adams
Eerdere bekende functies van Derek Adams
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Algemeen Directeur | 01-03-2022 | 01-11-2022 |
| Operationeel Directeur | 08-07-2021 | - | |
| President | 01-03-2022 | 01-11-2022 | |
| BLUEBIRD BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 20-03-2017 | 01-07-2021 |
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 01-02-2016 | 01-06-2016 |
| ALEXION PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2015 | 01-02-2016 |
Opleiding van Derek Adams
| University of Minnesota | Doctorate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| ALLOVIR, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
- Beurs
- Insiders
- Derek Adams
- Ervaring